98 related articles for article (PubMed ID: 11243382)
1. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.
Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD
Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382
[TBL] [Abstract][Full Text] [Related]
2. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
3. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
4. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
5. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
6. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
[TBL] [Abstract][Full Text] [Related]
7. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
8. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
9. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
Ono Y; Fukuhara N; Yoshie O
Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
[TBL] [Abstract][Full Text] [Related]
10. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development.
Robb L; Begley CG
Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726
[TBL] [Abstract][Full Text] [Related]
11. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
[TBL] [Abstract][Full Text] [Related]
12. Generation of Inducible
Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
14. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
15. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
16. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
Elwood NJ; Cook WD; Metcalf D; Begley CG
Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.
Lin YW; Aplan PD
Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429
[TBL] [Abstract][Full Text] [Related]
18. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
19. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis.
Göthert JR; Brake RL; Smeets M; Dührsen U; Begley CG; Izon DJ
Blood; 2007 Nov; 110(10):3753-62. PubMed ID: 17698635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
